Zhangzhou Pientzehuang Pharmaceutical Co Ltd: A Snapshot of Recent Performance and Overview

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., a prominent player in the health care sector, specializes in the manufacturing and marketing of traditional Chinese medications. Based in Zhangzhou, China, the company is renowned for its diverse product range, including Pientzehuang, Pientzehuang capsules, Pientzehuang lozenges, cough syrup, and other related products. The company’s commitment to traditional Chinese medicine has positioned it as a key player in the pharmaceutical industry.

As of May 15, 2025, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. saw its share price close at 208.7 CNH on the Shanghai Stock Exchange. This figure reflects a significant recovery from its 52-week low of 189.9 CNH, recorded on September 18, 2024. The company’s shares reached a 52-week high of 284.34 CNH on October 7, 2024, indicating a period of robust performance and investor confidence.

The company boasts a substantial market capitalization of 126,080,000,000 CNH, underscoring its significant presence in the pharmaceutical sector. Despite a high price-to-earnings ratio of 42, the company’s market valuation reflects its strong brand recognition and the enduring demand for its traditional Chinese medicine products.

Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. made its Initial Public Offering (IPO) on May 30, 2003, marking the beginning of its journey on the public market. Since then, it has maintained a steady growth trajectory, leveraging its expertise in traditional Chinese medicine to expand its product offerings and market reach.

For more information about the company and its products, interested parties can visit the official website at www.zzpzh.com . The company continues to focus on innovation and quality, ensuring that its products meet the evolving needs of consumers while preserving the rich heritage of traditional Chinese medicine.